U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C25H32O4
Molecular Weight 396.5192
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of NAXAPROSTENE

SMILES

[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C3CCCCC3)[C@@]1([H])C\C(C2)=C\C4=CC(=CC=C4)C(O)=O

InChI

InChIKey=OINUMRGCICIETD-CGKNXJIZSA-N
InChI=1S/C25H32O4/c26-23(18-6-2-1-3-7-18)10-9-21-22-14-17(13-20(22)15-24(21)27)11-16-5-4-8-19(12-16)25(28)29/h4-5,8-12,18,20-24,26-27H,1-3,6-7,13-15H2,(H,28,29)/b10-9+,17-11+/t20-,21+,22-,23+,24+/m0/s1

HIDE SMILES / InChI

Molecular Formula C25H32O4
Molecular Weight 396.5192
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 2
Optical Activity UNSPECIFIED

Naxaprostene (CG 4305) is a prostacyclin analogue, which causes concentration dependent inhibition of thrombocyte function. Naxaprostene is more selective for IP receptors and tends towards partial agonism. Naxaprostene prevented thrombotic arterial occlusion in rabbits.

Approval Year

PubMed

PubMed

TitleDatePubMed
Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
1986 Aug

Sample Use Guides

The antithrombotic efficacy of naxaprostene has been tested in rabbits with copper coil-induced carotid artery thrombosis. With oral pretreatment, 10 mg/kg naxaprostene prevented thrombotic arterial occlusion; with intraduodenal pretreatment the efficacy of naxaprostene was enhanced and 1 mg/kg was sufficient to exert an antithrombotic effect.
Route of Administration: Oral
In Vitro Use Guide
ADP-induced aggregation is inhibited 25% by 50 nmol/l CG 4305 (naxaprostene).
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:08:45 GMT 2023
Edited
by admin
on Fri Dec 15 16:08:45 GMT 2023
Record UNII
6QS1XD4508
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NAXAPROSTENE
INN  
INN  
Official Name English
naxaprostene [INN]
Common Name English
.ALPHA.-((2E,3AS,4R,5R,6AS)-4-((1E,3S)-3-CYCLOHEXYL-3-HYDROXYPROPENYL)HEXAHYDRO-5-HYDROXY-2(1H)-PENTALENYLIDENE)-M-TOLUIC ACID
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C78568
Created by admin on Fri Dec 15 16:08:45 GMT 2023 , Edited by admin on Fri Dec 15 16:08:45 GMT 2023
Code System Code Type Description
FDA UNII
6QS1XD4508
Created by admin on Fri Dec 15 16:08:45 GMT 2023 , Edited by admin on Fri Dec 15 16:08:45 GMT 2023
PRIMARY
EVMPD
SUB09172MIG
Created by admin on Fri Dec 15 16:08:45 GMT 2023 , Edited by admin on Fri Dec 15 16:08:45 GMT 2023
PRIMARY
SMS_ID
100000080344
Created by admin on Fri Dec 15 16:08:45 GMT 2023 , Edited by admin on Fri Dec 15 16:08:45 GMT 2023
PRIMARY
NCI_THESAURUS
C87383
Created by admin on Fri Dec 15 16:08:45 GMT 2023 , Edited by admin on Fri Dec 15 16:08:45 GMT 2023
PRIMARY
PUBCHEM
6446653
Created by admin on Fri Dec 15 16:08:45 GMT 2023 , Edited by admin on Fri Dec 15 16:08:45 GMT 2023
PRIMARY
EPA CompTox
DTXSID301024705
Created by admin on Fri Dec 15 16:08:45 GMT 2023 , Edited by admin on Fri Dec 15 16:08:45 GMT 2023
PRIMARY
ChEMBL
CHEMBL2105172
Created by admin on Fri Dec 15 16:08:45 GMT 2023 , Edited by admin on Fri Dec 15 16:08:45 GMT 2023
PRIMARY
CAS
87269-59-8
Created by admin on Fri Dec 15 16:08:45 GMT 2023 , Edited by admin on Fri Dec 15 16:08:45 GMT 2023
PRIMARY
INN
6189
Created by admin on Fri Dec 15 16:08:45 GMT 2023 , Edited by admin on Fri Dec 15 16:08:45 GMT 2023
PRIMARY
MESH
C050548
Created by admin on Fri Dec 15 16:08:45 GMT 2023 , Edited by admin on Fri Dec 15 16:08:45 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY